Symposium:
110. Kawasaki Disease
Friday, October 9, 2015: 8:30 AM-10:00 AM
Room: 29--ABCD

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the epidemiology, etiology, and biomarkers for Kawasaki disease
  • discuss the clinical presentation and diagnosis of Kawasaki disease
  • describe the management of and future directions for Kawasaki disease

Target Audience: Scientists, Researchers, Pharmacists, Nurses, Members-in-training, Investigators, Infectious diseases pediatricians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Trainee

Moderators:  Marsha S. Anderson, MD, FIDSA, University of Colorado School of Medicine and Children's Hospital Colorado and Adriana H. Tremoulet, MD, MAS, University of California, San Diego

Presentations:
8:30 AM
672
Kawasaki Disease: Epidemiology, Etiology, Biomarkers
Jane C. Burns, MD, FIDSA

9:00 AM
673
Kawasaki Disease: Clinical Presentation and Diagnosis
Preeti Jaggi, MD
9:30 AM
674
Kawasaki Disease: Management and Future Directions
Jane C. Burns, MD, FIDSA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-170-L01-P

Disclosures:

M. S. Anderson, None

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.